Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Spotlight Back On Indian Rotavirus Vaccine Controversy

Executive Summary

A public interest litigation (PIL) has sought to revive efforts to access segregated trial data from an indigenous oral rotavirus vaccine (Rotavac) in India amid concerns that it might be associated with a higher risk of intussusception in certain pockets of the country. And in a further dimension, an expert panel recently brought up a "representation" on the inclusion of intussusception in the vaccine's package insert.


Related Content

Indian Court Dismisses "Misconceived" PIL On Rotavirus Vaccine
India's rotavirus vaccine row: show me the data





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst